Posible uso excesivo de procedimientos en 3 etapas para la colitis ulcerosa activa

Kappelman  MD, Rifas-Shiman  SL, Kleinman  K,  et al.  The prevalence and geographic distribution of Crohn’s disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007;5(12):1424-1429.
2. Aratari  A, Papi  C, Clemente  V,  et al.  Colectomy rate in acute severe ulcerative colitis in the infliximab era. Dig Liver Dis. 2008;40(10):821-826.
3. Kirat  HT, Remzi  FH.  Technical aspects of ileoanal pouch surgery in patients with ulcerative colitis. Clin Colon Rectal Surg. 2010;23(4):239-247.
4. Symms  MR, Rawl  SM, Grant  M,  et al.  Sexual health and quality of life among male veterans with intestinal ostomies. Clin Nurse Spec. 2008;22(1):30-40.
5. Somashekar  U, Gupta  S, Soin  A, Nundy  S.  Functional outcome and quality of life following restorative proctocolectomy for ulcerative colitis in Indians. Int J Colorectal Dis. 2010;25(8):967-973.
6. Dabirian  A, Yaghmaei  F, Rassouli  M, Tafreshi  MZ.  Quality of life in ostomy patients: a qualitative study. Patient Prefer Adherence. 2010;5:1-5.
7. Hare  NC, Arnott  ID, Satsangi  J.  Therapeutic options in acute severe ulcerative colitis. Expert Rev Gastroenterol Hepatol. 2008;2(3):357-370.
8. Heuschen  UA, Hinz  U, Allemeyer  EH,  et al.  Risk factors for ileoanal J pouch-related septic complications in ulcerative colitis and familial adenomatous polyposis. Ann Surg. 2002;235(2):207-216.
9. Lim  M, Sagar  P, Abdulgader  A, Thekkinkattil  D, Burke  D.  The impact of preoperative immunomodulation on pouch-related septic complications after ileal pouch-anal anastomosis. Dis Colon Rectum. 2007;50(7):943-951.
10. Richardson  D, deMontbrun  S, Johnson  PM.  Surgical management of ulcerative colitis: a comparison of Canadian and American colorectal surgeons. Can J Surg. 2011;54(4):257-262.
11. Charlson  M, Szatrowski  TP, Peterson  J, Gold  J.  Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245-1251.
12. Gawande  AA, Kwaan  MR, Regenbogen  SE, Lipsitz  SA, Zinner  MJ.  An Apgar score for surgery. J Am Coll Surg. 2007;204(2):201-208.
13. Livingston  EH, Passaro  EP  Jr.  Postoperative ileus. Dig Dis Sci. 1990;35(1):121-132.
14. Sengul  N, Wexner  SD, Hui  SM,  et al.  Anatomic extent of colitis and disease severity are not predictors of pouchitis after restorative proctocolectomy for mucosal ulcerative colitis. Tech Coloproctol. 2006;10(1):29-36.
15. Lipman  JM, Kiran  RP, Shen  B, Remzi  F, Fazio  VW.  Perioperative factors during ileal pouch-anal anastomosis predict pouchitis. Dis Colon Rectum. 2011;54(3):311-317.
16. Nasmyth  DG, Williams  NS, Johnston  D.  Comparison of the function of triplicated and duplicated pelvic ileal reservoirs after mucosal proctectomy and ileo-anal anastomosis for ulcerative colitis and adenomatous polyposis. Br J Surg. 1986;73(5):361-366.
17. Penna  C, Daude  F, Parc  R,  et al.  Previous subtotal colectomy with ileostomy and sigmoidostomy improves the morbidity and early functional results after ileal pouch-anal anastomosis in ulcerative colitis. Dis Colon Rectum. 1993;36(4):343-348.
18. Nicholls  RJ, Holt  SD, Lubowski  DZ.  Restorative proctocolectomy with ileal reservoir: comparison of two-stage vs three-stage procedures and analysis of factors that might affect outcome. Dis Colon Rectum. 1989;32(4):323-326.
19. Galandiuk  S, Pemberton  JH, Tsao  J, Ilstrup  DM, Wolff  BG.  Delayed ileal pouch-anal anastomosis: complications and functional results. Dis Colon Rectum. 1991;34(9):755-758.
20. Swenson  BR, Hollenbeak  CS, Poritz  LS, Koltun  WA.  Modified two-stage ileal pouch-anal anastomosis: equivalent outcomes with less resource utilization. Dis Colon Rectum. 2005;48(2):256-261.
21. Selvasekar  CR, Cima  RR, Larson  DW,  et al.  Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. J Am Coll Surg. 2007;204(5):956-963.
22. Subramanian  V, Saxena  S, Kang  JY, Pollok  RC.  Preoperative steroid use and risk of postoperative complications in patients with inflammatory bowel disease undergoing abdominal surgery. Am J Gastroenterol. 2008;103(9):2373-2381.
23. Ferrante  M, D’Hoore  A, Vermeire  S,  et al.  Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis. Inflamm Bowel Dis. 2009;15(7):1062-1070.
24. Yang  Z, Wu  Q, Wu  K, Fan  D.  Meta-analysis: pre-operative infliximab treatment and short-term post-operative complications in patients with ulcerative colitis. Aliment Pharmacol Ther. 2010;31(4):486-492.
25. Meagher  AP, Farouk  R, Dozois  RR, Kelly  KA, Pemberton  JH.  J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients. Br J Surg. 1998;85(6):800-803.
26. Fazio  VW, Tekkis  PP, Remzi  F,  et al.  Quantification of risk for pouch failure after ileal pouch anal anastomosis surgery. Ann Surg. 2003;238(4):605-617
27. MacLean  AR, Cohen  Z, MacRae  HM,  et al.  Risk of small bowel obstruction after the ileal pouch-anal anastomosis. Ann Surg. 2002;235(2):200-206.
28.  Swenson  BR, Hollenbeak  CS, Koltun  WA.  Factors affecting cost and length of stay associated with the ileal pouch-anal anastomosis. Dis Colon Rectum. 2003;46(6):754-761.